A Narrative Review of Continuing Professional Development Needs for Pharmacists with Respect to Pre-exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV)
Pre-exposure prophylaxis (PrEP) for the human immunodeficiency virus (HIV) is rapidly increasing in use worldwide, with many countries now publicly funding use for high risk populations. Pharmacists, as front-line care providers, must have the necessary knowledge, skills and attitudes to effectively...
Main Authors: | Kyle J. Wilby, Alesha J. Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Pharmacy |
Subjects: | |
Online Access: | https://www.mdpi.com/2226-4787/8/2/84 |
Similar Items
-
Effectiveness of HIV Pre-Exposure Prophylaxis (PrEP) in Pakistan
by: Muhammad Waqar Aslam Khan, Usman Nawaz, Ali Faheem, Mehwish Memon, Mahak Memon, Aleem Ul Haq
Published: (2023-03-01) -
Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursement
by: Patrick Ahaus, et al.
Published: (2022-09-01) -
Preparing for long‐acting PrEP delivery: building on lessons from oral PrEP
by: Connie Celum, et al.
Published: (2023-07-01) -
Persistence in a pharmacist-led, same-day PrEP program in Mississippi: a mixed-methods study
by: Christine M. Khosropour, et al.
Published: (2023-06-01) -
What motivated men to start PrEP? A cross-section of men starting PrEP in Buffalo city municipality, South Africa
by: Philip John Smith, et al.
Published: (2023-03-01)